Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Professor Roger Taylor is a Consultant Clinical Oncologist specialising in the treatment of patients with brain tumours and lymphoma. Professor Taylor was born and educated in Swansea, and trained in Medicine at University College, Oxford and St Bartholomew’s Hospital Medical College. His oncology training was at the Royal Marsden Hospital, Royal London Hospital and Western General Hospital, Edinburgh.
He worked as a Consultant Clinical Oncologist in Leeds from 1987-2006, specialising mainly in the treatment of children with cancer. Professor Taylor returned to Wales in 2006, to work in the South West Wales Cancer Centre, Singleton Hospital, Swansea and the College of Medicine, Swansea University.
Professor Taylor provides specialist advice on proton radiotherapy in Wales, and currently is undertaking research in this field. He is author of many papers on the treatment of children with cancer, particularly brain tumours.
Proton Beam Therapy
This consultant has received training from the Rutherford Cancer Centres in the delivery of proton beam therapy. The programme, Proton Therapy Clinical Education, in conjunction with The Perelman School of Medicine at the University of Pennsylvania and IBA, the leading proton beam therapy solutions manufacturer, involves oncologists gaining practical experience in Penn’s Roberts Proton Therapy Center – one of the world’s leading centres of proton therapy research and expertise.